News

Congrats to Long-Time GMA Collaborators

August 8, 2016
Thumbnail image for Congrats to Long-Time GMA Collaborators

The recent Nature Medicine publication, ‘A rapid pro-hemostatic approach to overcome direct oral anticoagulants,’ addresses the growing need for effective and clinically viable drugs that control bleeding after anticoagulant administration. Researchers at The Children’s Hospital of Philadelphia have developed a potent variant, designated Factor Xa(I16L), that significantly reduces bleeding and restores normal hemostatic processes. Congratulations […]

Read the full article →

GMA Antibodies Featured in Blood Publication

August 4, 2016
Thumbnail image for GMA Antibodies Featured in Blood Publication

The recent Blood article, ‘Prophylactic efficacy of BeneFIX vs Alprolix in hemophilia B mice,’ features three GMA antibodies. Antibodies to human Factor IX (GMA-101), human Factor X (GMA-540), and human Factor VII (GMA-213) were used in combination with an anti-collagen antibody to demonstrate localization of coagulation factors in human tissues. The study finds that not […]

Read the full article →

New Additions to Our Anti-Factor IX Product Line

July 26, 2016
Thumbnail image for New Additions to Our Anti-Factor IX Product Line

Green Mountain Antibodies is excited to announce the expansion of our anti-Factor IX product line of monoclonal antibodies. Thank you to all of our collaborators who have helped us in determining specificities of interest and testing products in the developmental stage; our line now contains an additional 6 antibodies with more detailed information on the […]

Read the full article →

Gordon Research Conference on Hemostasis

July 20, 2016
Thumbnail image for Gordon Research Conference on Hemostasis

From July 24th to 29th, Amy Griffiths and Dr. Bill Church will be attending the Gordon Research Conference on Hemostasis at the Stoweflake Conference Center, located in Stowe, VT. They will be participating in discussions on a variety of conference topics, including the relationship between Von Willebrand Factor and Factor VIII and the role of […]

Read the full article →

New Antibodies to S. aureus virulence factors to be discussed at American Society of Microbiology meeting in Boston, June 2016.

May 3, 2016

In collaboration with Drs. Paul Bock and Ashok Maddur of Vanderbilt University, and Dr. Pete Panizzi of Auburn University, Green Mountain Antibodies scientists have prepared monoclonal antibodies to the major known procoagulant virulence factors from S. aureus: coagulase and von Willebrand factor binding protein.  The rationale behind preparing these antibodies is the hypothesis that blocking […]

Read the full article →

Kaitlyn Begins promoted to Research Project Manager

May 3, 2016

  Kaitlyn Begins was promoted to Research Project Manager effective May 1, 2016.  Kaitlyn joined Green Mountain Antibodies as an intern following graduation from St. Michael’s College and became a full time lab technician in the fall of 2011.  In addition to her responsibilities overseeing our variable region sequencing and human antibody construction and expression […]

Read the full article →

ASH 2015

December 17, 2015

Green Mountain Antibodies attended the annual American Society of Hematology (ASH) conference in Orlando, Florida, from December 5th-8th.  We enjoyed catching up with our colleagues and collaborators, hearing about developments in coagulation science, and now look forward to developing some new antibodies to meet the needs of the changing field.  

Read the full article →

Attending the American Society of Hematology (ASH)

November 9, 2015

Green Mountain Antibodies will be attending the  American Society of Hematology (ASH) meeting in Orlando, December 5-8, 2015. If you would like to arrange a meeting with us while at ASH, contact amyg@greenmoab.com or call 1-802-865-6230. 

Read the full article →

Welcome Joseph P. Gardner

September 17, 2015

Joe Gardner has joined Green Mountain Antibodies as Sales Manager of Antibody Services. Joe is a graduate of Wesleyan University and began his career as a research scientist at Yale developing monoclonal antibodies to markers of acute and chronic forms of myelogenous leukemia. At Pfizer he established the Molecular Interactions Group (MIG) within the Immunology/Oncology […]

Read the full article →

An Anti-Staphylocoagulase Monoclonal Antibody.

September 8, 2015

On June 24th Green Mountain Antibodies presented this abstract of an anti-Staphylococcus antibody at the 25th International Society of Thrombosis and Haemostasis meeting, in Toronto Canada. Click the video below to play the presentation. Background: Prothrombin and fibrinogen play important roles in pathogenesis of certain bacterial infections. Controlling host coagulation might represent a new strategy […]

Read the full article →